Latest Fairmount Funds Management LLC Stock Portfolio
$917Million
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Fairmount Funds Management LLC and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Fairmount Funds Management LLC reported an equity portfolio of $917.4 Millions as of 31 Mar, 2024.
The top stock holdings of Fairmount Funds Management LLC are AXSM, NUVL, . The fund has invested 20.5% of it's portfolio in AXSOME THERAPEUTICS INC and 15.8% of portfolio in NUVALENT INC.
The fund managers got completely rid off IMMUNOGEN INC (IMGN), RAYZEBIO INC and ARGENX SE (ARGX) stocks. They significantly reduced their stock positions in APOGEE THERAPEUTICS INC. Fairmount Funds Management LLC opened new stock positions in PROTAGONIST THERAPEUTICS INC (PTGX) and GERON CORP (GERN). The fund showed a lot of confidence in some stocks as they added substantially to ENLIVEN THERAPEUTICS INC, VIRIDIAN THERAPEUTICS INC (VRDN) and COGENT BIOSCIENCES INC (COGT).
The top stock holdings of Fairmount Funds Management LLC are AXSM, NUVL, . The fund has invested 20.5% of it's portfolio in AXSOME THERAPEUTICS INC and 15.8% of portfolio in NUVALENT INC.
The fund managers got completely rid off IMMUNOGEN INC (IMGN), RAYZEBIO INC and ARGENX SE (ARGX) stocks. They significantly reduced their stock positions in APOGEE THERAPEUTICS INC. Fairmount Funds Management LLC opened new stock positions in PROTAGONIST THERAPEUTICS INC (PTGX) and GERON CORP (GERN). The fund showed a lot of confidence in some stocks as they added substantially to ENLIVEN THERAPEUTICS INC, VIRIDIAN THERAPEUTICS INC (VRDN) and COGENT BIOSCIENCES INC (COGT).
New Buys
| Ticker | $ Bought |
|---|---|
| PROTAGONIST THERAPEUTICS INC | 26,959,600 |
| GERON CORP | 22,000,000 |
New stocks bought by Fairmount Funds Management LLC
Additions
| Ticker | % Inc. |
|---|---|
| ENLIVEN THERAPEUTICS INC | 50.27 |
| DIANTHUS THERAPEUTICS INC | 43.26 |
| VIRIDIAN THERAPEUTICS INC | 34.77 |
| COGENT BIOSCIENCES INC | 32.78 |
| KINIKSA PHARMACEUTICALS LTD | 11.15 |
Additions to existing portfolio by Fairmount Funds Management LLC
Reductions
| Ticker | % Reduced |
|---|---|
| APOGEE THERAPEUTICS INC | -30.35 |
Fairmount Funds Management LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| IMMUNOGEN INC | -175,812,000 |
| RAYZEBIO INC | -77,459,400 |
| ARGENX SE | -42,951,700 |
Fairmount Funds Management LLC got rid off the above stocks
Current Stock Holdings of Fairmount Funds Management LLC
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| AGLE | SPYRE THERAPEUTICS INC | 1.56 | 378,421 | 14,353,500 | UNCHANGED | 0.00 | |
| ARGX | ARGENX SE | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ATXS | ASTRIA THERAPEUTICS INC | 5.45 | 3,554,130 | 50,024,400 | UNCHANGED | 0.00 | |
| AXSM | AXSOME THERAPEUTICS INC | 20.53 | 2,360,080 | 188,334,000 | UNCHANGED | 0.00 | |
| COGT | COGENT BIOSCIENCES INC | 3.46 | 4,725,640 | 31,756,300 | ADDED | 32.78 | |
| GERN | GERON CORP | 2.40 | 6,666,670 | 22,000,000 | NEW | ||
| IMGN | IMMUNOGEN INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | 6.89 | 3,204,840 | 63,231,500 | ADDED | 11.15 | |
| MRUS | MERUS N V | 3.52 | 717,254 | 32,297,900 | UNCHANGED | 0.00 | |
| NUVL | NUVALENT INC | 15.75 | 1,924,630 | 144,520,000 | UNCHANGED | 0.00 | |
| PTGX | PROTAGONIST THERAPEUTICS INC | 2.94 | 931,890 | 26,959,600 | NEW | ||
| TERN | TERNS PHARMACEUTICALS INC | 1.46 | 2,040,000 | 13,382,400 | UNCHANGED | 0.00 | |
| TYRA | TYRA BIOSCIENCES INC | 2.49 | 1,393,330 | 22,850,600 | UNCHANGED | 0.00 | |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3.52 | 1,845,810 | 32,320,200 | ADDED | 34.77 | |
| APOGEE THERAPEUTICS INC | 14.84 | 2,048,650 | 136,133,000 | REDUCED | -30.35 | ||
| DIANTHUS THERAPEUTICS INC | 9.04 | 2,762,840 | 82,885,100 | ADDED | 43.26 | ||
| ENLIVEN THERAPEUTICS INC | 6.14 | 3,202,800 | 56,337,200 | ADDED | 50.27 | ||
| RAYZEBIO INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 |